106 related articles for article (PubMed ID: 2617229)
21. [Sjögren's syndrome and multiple sclerosis].
Iñiguez C; Mauri J; Medrano M; Larrodé P; Santos S; Pina J; Morales F
Neurologia; 2001 May; 16(5):232-5. PubMed ID: 11412725
[TBL] [Abstract][Full Text] [Related]
22. The SSB-positive/SSA-negative antibody profile is not associated with key phenotypic features of Sjögren's syndrome.
Baer AN; McAdams DeMarco M; Shiboski SC; Lam MY; Challacombe S; Daniels TE; Dong Y; Greenspan JS; Kirkham BW; Lanfranchi HE; Schiødt M; Srinivasan M; Umehara H; Vivino FB; Vollenweider CF; Zhao Y; Criswell LA; Shiboski CH;
Ann Rheum Dis; 2015 Aug; 74(8):1557-61. PubMed ID: 25735642
[TBL] [Abstract][Full Text] [Related]
23. Myelopathy in seronegative Sjögren syndrome and/or primary progressive multiple sclerosis.
Pericot I; Brieva L; Tintoré M; Río J; Sastre-Garriga J; Nos C; Montalban X
Mult Scler; 2003 Jun; 9(3):256-9. PubMed ID: 12814172
[TBL] [Abstract][Full Text] [Related]
24. Anti-Ro (SSA)/La (SSB) antibodies and Sjögren's syndrome.
Moutsopoulos HM; Zerva LV
Clin Rheumatol; 1990 Mar; 9(1 Suppl 1):123-30. PubMed ID: 2203591
[TBL] [Abstract][Full Text] [Related]
25. A case of Sjögren's syndrome or multiple sclerosis? A diagnostic and therapeutic dilemma.
Thong BY; Venketasubramanian N
Rheumatol Int; 2002 Nov; 22(6):256-8. PubMed ID: 12494271
[TBL] [Abstract][Full Text] [Related]
26. Usefulness of antibodies and minor salivary gland biopsy in the study of sicca syndrome in daily clinical practice.
Santiago ML; Seisdedos MR; Garcia Salinas RN; Catalán Pellet A; Villalón L; Secco A
Reumatol Clin; 2015; 11(3):156-60. PubMed ID: 25579246
[TBL] [Abstract][Full Text] [Related]
27. Prognostic factors for the clinical severity of keratoconjunctivitis sicca in patients with Sjogren's syndrome.
Chung JK; Kim MK; Wee WR
Br J Ophthalmol; 2012 Feb; 96(2):240-5. PubMed ID: 21558290
[TBL] [Abstract][Full Text] [Related]
28. 'Seronegative' Sjögren's syndrome manifested as a subset of chronic fatigue syndrome.
Nishikai M; Akiya K; Tojo T; Onoda N; Tani M; Shimizu K
Br J Rheumatol; 1996 May; 35(5):471-4. PubMed ID: 8646439
[TBL] [Abstract][Full Text] [Related]
29. [Soluble SS-A, SS-B and RNP antinuclear antigen antibodies in 66 cases of pure or associated forms of Gougerot-Sjögren syndrome].
Meyer O; Chabrand-Ahond L; Kahn MF; Ryckewaert A
Rev Rhum Mal Osteoartic; 1982 May; 49(6):421-5. PubMed ID: 6810443
[TBL] [Abstract][Full Text] [Related]
30. Impact of double positive for anti-centromere and anti-SS-a/Ro antibodies on clinicopathological characteristics of primary Sjögren's syndrome: a retrospective cohort study.
Suzuki Y; Fujii H; Nomura H; Mizushima I; Yamada K; Yamagishi M; Kawano M
Mod Rheumatol; 2018 Sep; 28(5):872-878. PubMed ID: 29251022
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of primary Sjögren's syndrome in patients with multiple sclerosis.
Miró J; Peña-Sagredo JL; Berciano J; Insúa S; Leno C; Velarde R
Ann Neurol; 1990 May; 27(5):582-4. PubMed ID: 2136584
[TBL] [Abstract][Full Text] [Related]
32. The relationship between anti-Ro (SS-A) antibody-positive Sjögren's syndrome and anti-Ro (SS-A) antibody-positive lupus erythematosus.
Provost TT; Talal N; Harley JB; Reichlin M; Alexander E
Arch Dermatol; 1988 Jan; 124(1):63-71. PubMed ID: 3257371
[TBL] [Abstract][Full Text] [Related]
33. [Autoantibodies in patients with Sjögren's syndrome and their clinical significance].
Miyawaki S
Nihon Rinsho; 1995 Oct; 53(10):2422-8. PubMed ID: 8531349
[TBL] [Abstract][Full Text] [Related]
34. Sicca syndrome associated with hepatitis C virus infection.
Jorgensen C; Legouffe MC; Perney P; Coste J; Tissot B; Segarra C; Bologna C; Bourrat L; Combe B; Blanc F; Sany J
Arthritis Rheum; 1996 Jul; 39(7):1166-71. PubMed ID: 8670326
[TBL] [Abstract][Full Text] [Related]
35. [Cutaneous manifestations of primary Sjögren's syndrome].
Nishiyama S; Miyawaki S; Hashimoto T
Nihon Rinsho; 1995 Oct; 53(10):2551-6. PubMed ID: 8531372
[TBL] [Abstract][Full Text] [Related]
36. Autoantibodies and the spectrum of Sjögren's syndrome.
Martinez-Lavin M; Vaughan JH; Tan EM
Ann Intern Med; 1979 Aug; 91(2):185-90. PubMed ID: 157095
[TBL] [Abstract][Full Text] [Related]
37. Hepatitis C virus infection and primary Sjögren's syndrome: a clinical and serologic description of 9 patients.
Ceribelli A; Cavazzana I; Cattaneo R; Franceschini F
Autoimmun Rev; 2008 Dec; 8(2):92-4. PubMed ID: 18692602
[TBL] [Abstract][Full Text] [Related]
38. Usefulness of IgA Anti-α-fodrin Antibodies in Combination with Rheumatoid Factor and/or Antinuclear Antibodies as Substitute Immunological Criterion in Sjögren Syndrome with Negative Anti-SSA/SSB Antibodies.
Hernández-Molina G; Nuñez-Alvarez C; Avila-Casado C; Llorente L; Hernández-Hernández C; Calderillo ML; Marroquín V; Recillas-Gispert C; Romero-Díaz J; Sánchez-Guerrero J
J Rheumatol; 2016 Oct; 43(10):1852-1857. PubMed ID: 27481899
[TBL] [Abstract][Full Text] [Related]
39. Acute iritis associated with primary Sjögren's syndrome and high-titer anti-SS-A/Ro and anti-SS-B/La antibodies. Treatment with combination immunosuppressive therapy.
Bridges AJ; Burns RP
Arthritis Rheum; 1992 May; 35(5):560-3. PubMed ID: 1575789
[TBL] [Abstract][Full Text] [Related]
40. Alpha-fodrin autoantibodies are reliable diagnostic markers for juvenile and adult Sjogren's syndrome.
Lawind MF; Alyasky A; Elwan NM; Mourad H; Al-Bendary A
Egypt J Immunol; 2004; 11(1):75-81. PubMed ID: 15724389
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
